Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

194 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Rethinking Surge Preparedness After COVID-19: Effective Patient Load Balancing Within Health Systems and Beyond.
Mandel-Ricci J, Belfi K, Shapiro J, Wiener A, Cintron BS, Warshaw A, Gustafson C, Zaylor A, Brannon H, Evans R, Roldan-Sanchez K, D'Angelo J, Berkowitz J, Iavicoli L, Salway RJ, Prieskorn K, Francois F, Levine S, Gardner J, Kesting L. Mandel-Ricci J, et al. Health Secur. 2022 Nov-Dec;20(6):497-503. doi: 10.1089/hs.2022.0059. Epub 2022 Nov 18. Health Secur. 2022. PMID: 36399608
Measurable Residual FLT3 Internal Tandem Duplication Before Allogeneic Transplant for Acute Myeloid Leukemia.
Dillon LW, Gui G, Ravindra N, Andrew G, Mukherjee D, Wong ZC, Huang Y, Gerhold J, Holman M, D'Angelo J, Miller J, Higgins J, Salk JJ, Auletta JJ, El Chaer F, Devine SM, Jimenez-Jimenez AM, De Lima MJG, Litzow MR, Kebriaei P, Saber W, Spellman SR, Zeger SL, Page KM, Hourigan CS. Dillon LW, et al. Among authors: d angelo j. JAMA Oncol. 2024 May 2:e240985. doi: 10.1001/jamaoncol.2024.0985. Online ahead of print. JAMA Oncol. 2024. PMID: 38696205
Acceptability and tolerability of long-acting injectable cabotegravir or rilpivirine in the first cohort of virologically suppressed adolescents living with HIV (IMPAACT 2017/MOCHA): a secondary analysis of a phase 1/2, multicentre, open-label, non-comparative dose-finding study.
Lowenthal ED, Chapman J, Ohrenschall R, Calabrese K, Baltrusaitis K, Heckman B, Yin DE, Agwu AL, Harrington C, Van Solingen-Ristea RM, McCoig CC, Adeyeye A, Kneebone J, Chounta V, Smith-Anderson C, Camacho-Gonzalez A, D'Angelo J, Bearden A, Crauwels H, Huang J, Buisson S, Milligan R, Ward S, Bolton-Moore C, Gaur AH; IMPAACT 2017 Collaborators; IMPAACT 2017 Team. Lowenthal ED, et al. Among authors: d angelo j. Lancet HIV. 2024 Apr;11(4):e222-e232. doi: 10.1016/S2352-3018(23)00301-6. Lancet HIV. 2024. PMID: 38538161 Clinical Trial.
BBA: 2024 and beyond.
Otzen D, d'Angelo J. Otzen D, et al. Among authors: d angelo j. Biochim Biophys Acta Gen Subj. 2024 Feb;1868(2):130524. doi: 10.1016/j.bbagen.2023.130524. Epub 2023 Nov 21. Biochim Biophys Acta Gen Subj. 2024. PMID: 37992999 No abstract available.
Roses, thorns, and buds: Coping with failure in surgery.
D'Angelo AD, Tevis SE, D'Angelo JD. D'Angelo AD, et al. Among authors: d angelo jd. Am J Surg. 2024 Jan;227:247-248. doi: 10.1016/j.amjsurg.2023.08.027. Epub 2023 Aug 30. Am J Surg. 2024. PMID: 37690909 No abstract available.
194 results